PRAME and synovial sarcoma: PRAME, a repressor of retinoic acid receptor-mediated differentiation and apoptosis, is expressed in 70% of SS cases (152/216), although it has also been detected at a high frequency in some other malignancies, including myxoid liposarcomas, some carcinomas, and melanomas [75].